News

Effect of statins on aggression varies according to age, sex

16.07.20151676

Men and women experienced different effects on aggression from treatment with statins, with men exhibiting a decrease and women an increase in aggression, according to results from the UCSD Statin Study.

Non-vitamin K antagonist oral anticoagulants do not increase cerebral microbleeds

15.07.20151777

Non-vitamin K antagonist oral anticoagulants do not increase the likelihood of cerebral microbleeds in patients with non-valvular atrial fibrillation, according to study results published in the Journal of Stroke and Cerebrovascular Diseases.

Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study

14.07.20151665

Patients with heart failure in sinus rhythm are at an increased risk of thromboembolic complications.

Serum Triglyceride Levels and Cardiovascular Disease Events in Koreans

13.07.20151771

Hypercholesterolemia, especially elevated levels of LDL-cholesterol, is a well-known risk factor for cardiovascular disease (CVD).

High VTE recurrence risk persists for at least 3 years

10.07.20151628

The risk of recurrence following an initial episode of venous thromboembolism is highest in the first 3 months, but remains high for up to 3 years, according to findings from a population-based study involving 2,989 adults.

Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial

09.07.20151825

The Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events (CHANCE) trial showed that the combined treatment of clopidogrel and aspirin decreases the 90-day risk of stroke without increasing hemorrhage in comparison with aspirin alone, but provided insufficient data to establish whether the benefit persisted over a longer period of time beyond the trial termination.

Extended warfarin delays return of unprovoked pulmonary embolism

08.07.20151570

Adding an extra 18 months of warfarin therapy to the standard 6 months of anticoagulation delays the recurrence of venous thrombosis in patients who have a first episode of unprovoked pulmonary embolism.